ASCO24: The Evolving Role of Biomarkers in Treatment-Resistant and Refractory Cancers
0 mins read
6 June 2024
Jump to a slide with the slide dots.
Prevalence of Soft Tissue Sarcoma (STS) Subtypes in the US, Risk of Metastases at Diagnosis, and Survival Outcomes
Soft tissue sarcomas (STS) are heterogeneous malignancies with diverse clinical presentations and outcomes. This study...
Read moreAI’s Transformative Influence on Medical Communications
Physicians and healthcare professionals (HCPs) struggle with the vast amounts of new information provided to them, related to patient care. As...
Read more